Kezar Life Sciences Inc.

KZR | NASDAQ

Price Alert Chart Builder DCF Calculator

$7.29

$0 (0.00%)

At close: May 11, 2026, 4:00 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.00%

(1D)

Rating

Updated: Apr 10, 2026

Fundamentals Weak

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $53.86M

1D Range

7.29 7.29

52W Range

3.53 7.55

Valuation (TTM)

PE -0.95

PB 0.77

EV/EBITDA 0.33

Valuation (NTM)

Forward PE N/A

Forward PEG -0.03

Price Target $11

Cash Flow

FCF Yield -96.2%

SBC Adj. FCF Yield -112.8%

SBC Impact -17.3%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y -150.0% | 0.0%

Dil EPS 3Y | 5Y -74.2% | -54.2%

FCF 3Y | 5Y 22.7% | -5.1%

Returns

ROA -66.5%

ROE -58.4%

ROIC -63.1%

Financial Health

Net Cash

$71.88M

Current Ratio 24.46

Interest Coverage -50.01

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and ca...

Sector Healthcare

Industry Biotechnology

Employees 55

IPO Date Jun 20, 2018

Website www.kezarlifesciences.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Hold

Price Target

Downside

-3.98%

Buy (0)

Hold (2)

Sell (0)

Analyst Details ➞